Rapamycin inhibits hepatectomy-induced stimulation of metastatic tumor growth by reduction of angiogenesis, microvascular blood perfusion, and tumor cell proliferation

Annals of Surgical Oncology

Volumn 16, Issue 9, 2009, Pages 2629-2637

  Rupertus, Kathrin ^a   Dahlem, Christian ^a   Menger, Michael D ^a   Schilling, Martin K ^a   Kollmar, Otto ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; GREEN FLUORESCENT PROTEIN; RAPAMYCIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; GENETIC TRANSFECTION; HISTOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LIVER REGENERATION; METASTASIS; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN;

ADENOCARCINOMA; ANGIOGENESIS INHIBITORS; ANIMALS; APOPTOSIS; CELL CYCLE; CELL PROLIFERATION; COLORECTAL NEOPLASMS; CYCLOSPORINE; FEMALE; HEPATECTOMY; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOSUPPRESSIVE AGENTS; IN SITU NICK-END LABELING; LIVER REGENERATION; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROCIRCULATION; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN KINASES; SIROLIMUS; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 68949216268     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0564-8     Document Type: Article

References (36)

1. EK Abdalla JN Vauthey LM Ellis et al 2004 Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases Ann Surg. 239 818 827
2. TM Pawlik CR Scoggins D Zorzi et al 2005 Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases Ann Surg. 241 715 722
3. H Oe T Kaido A Mori H Onodera M Imamura 2005 Hepatocyte growth factor as well as vascular endothelial growth factor gene induction effectively promotes liver regeneration after hepatectomy in Solt-Farber rats Hepatogastroenterology. 52 1393 1397
4. SS Yoon SH Kim M Gonen et al 2006 Profile of plasma angiogenic factors before and after hepatectomy for colorectal cancer liver metastases Ann Surg Oncol. 13 353 362
5. Y Panis J Ribeiro Y Chrétien B Nordlinger 1992 Dormant liver metastases: an experimental study Br J Surg 79 221 223
6. A Picardo HM Karpoff B Ng J Lee MF Brennan Y Fong 1998 Partial hepatectomy accelerates local tumor growth: potential roles of local cytokine activation Surgery 124 57 64
7. K Rupertus O Kollmar C Scheuer B Junker MD Menger MK Schilling 2007 Major but not minor hepatectomy accelerates engraftment of extrahepatic tumor cells Clin Exp Metastasis. 24 39 48
8. GD Slooter RL Marquet J Jeekel JN Ijzermans 1995 Tumour growth stimulation after partial hepatectomy can be reduced by treatment with tumour necrosis factor alpha Br J Surg. 82 129 132
9. B Nordlinger H Sorbye B Glimelius et al 2008 Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial Lancet. 371 1007 1016
10. TA Drixler IH Borel Rinkes ED Ritchie TJ van Vroonhoven MF Gebbink EE Voest 2000 Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastases after partial hepatectomy Cancer Res. 60 1761 1765
11. C Gridelli P Maione A Rossi 2008 The potential role of mTOR inhibitors in non-small cell lung cancer Oncologist. 13 139 147
12. SM Flechner J Kobashigawa G Klintmalm 2008 Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity Clin Transplant. 22 1 15
13. M Guba P von Breitenbuch M Steinbauer et al 2002 Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor Nat Med. 8 128 135
14. WW Ma M Hidalgo 2007 Exploiting novel molecular targets in gastrointestinal cancers World J Gastroenterol. 13 5845 5856
15. D Palmes A Zibert T Budny et al 2008 Impact of rapamycin on liver regeneration Virchows Arch. 452 545 557
16. O Kollmar MK Schilling MD Menger 2004 Experimental liver metastasis: standards for local cell implantation to study isolated tumor growth in mice Clin Exp Metastasis. 21 453 460
17. MD Menger MW Laschke B Vollmar 2002 Viewing the microcirculation through the window: some twenty years experience with the hamster dorsal skinfold chamber Eur Surg Res. 34 83 91
18. O Kollmar K Rupertus C Scheuer B Junker B Tilton MK Schilling et al 2007 Stromal cell-derived factor-1 promotes cell migration and tumor growth of colorectal metastasis Neoplasia. 9 862 870
19. C Contaldo C Meier A Elsherbiny Y Harder O Trentz MD Menger et al 2007 Human recombinant erythropoietin protects the striated muscle microcirculation of the dorsal skinfold from postischemic injury in mice Am J Physiol Heart Circ Physiol. 293 H274 H283
20. O Kollmar M Corsten C Scheuer B Vollmar MK Schilling MD Menger 2007 Portal branch ligation induces a hepatic arterial buffer response, microvascular remodeling, normoxygenation, and cell proliferation in portal blood-deprived liver tissue Am J Physiol Gastrointest Liver Physiol. 292 G1534 G1542
21. A Francavilla TE Starzl C Scotti et al 1992 Inhibition of liver, kidney, and intestine regeneration by rapamycin Transplantation. 53 496 498
22. YP Jiang LM Ballou RZ Lin 2001 Rapamycin-insensitive regulation of 4e-BP1 in regenerating rat liver J Biol Chem. 276 10943 10951
23. H Kirimlioglu V Kirimlioglu S Yilmaz S Coban E Turkmen C Ara 2006 Liver pathology and cell proliferation after calcineurin inhibitors and antiproliferative drugs following partial hepatectomy in rats Transplant Proc. 38 622 626
24. A Francavilla TE Starzl M Barone et al 1991 Studies on mechanisms of augmentation of liver regeneration by cyclosporine and FK 506 Hepatology. 14 140 143
25. S Faivre G Kroemer E Raymond 2006 Current development of mTOR inhibitors as anticancer agents Nat Rev Drug Discov. 5 671 688
26. M Guba M Yezhelyev ME Eichhorn et al 2005 Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VEGF Blood. 105 4463 4469
27. I Vivanco CL Sawyers 2002 The phosphatidylinositol 3-Kinase AKT pathway in human cancer Nat Rev Cancer. 2 489 501
28. T Schmelzle MN Hall 2000 TOR, a central controller of cell growth Cell. 103 253 262
29. J Nourse E Firpo WM Flanagan et al 1994 Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin Nature. 372 570 573
30. CJ Bruns GE Koehl M Guba et al 2004 Rapamycin-induced endothelial cell death and tumor vessel thrombosis potentiate cytotoxic therapy against pancreatic cancer Clin Cancer Res. 10 2109 2119
31. P Vajkoczy B Vollmar B Wolf MD Menger 1999 Effects of cyclosporine A on the process of vascularization of freely transplanted islets of Langerhans J Mol Med. 77 111 114
32. C Wilasrusmee I Yusupov P Ondocin D Bruch S Kittur S Wilasrusmee et al 2005 Angiocidal effect of Cyclosporin A: a new therapeutic approach for pathogenic angiogenesis Int Angiol. 24 372 379
33. G Shah FA Middleton KL Gentile S Tripathi D Bruch KG Maier et al 2008 Cyclosporine inhibition of angiogenesis involves the transcription factor HESR1 J Surg Res. 149 171 176
34. FH Rad H Le Buanec S Paturance et al 2007 VEGF kinoid vaccine, a therapeutic approach against tumor angiogenesis and metastases Proc Natl Acad Sci U S A. 104 2837 2842
35. Y Tsuchiya S Sawada I Yoshioka et al 2003 Increased surgical stress promotes tumor metastasis Surgery. 133 547 555
36. MD Menger B Vollmar 2004 Surgical trauma: hyperinflammation versus immuno-suppression? Langenbecks Arch Surg. 389 475 484